Rationale for the Rapid Program (foundation paper)
Currow, D.C., Rowett. D., Doogue, M., To, T.H.M., Abernethy, A.P. (2012) An international initiative to create a collaborative for pharmacovigilance in hospice and palliative care clinical practice. Journal of Palliative Medicine 15(3):282–6. doi: 10.1089/jpm.2012.9605 [opens external site]
Evaluation of the Rapid Program
Hunt, J, Brown, L, Faekas, B, Doogue, M, Rowett, D, Luckett, T, Morgan, D, Reed-Cox, K, Sheehan, C, Tuffin, P, Currow, D.C. (2020) Evaluation of the IMPACCT Rapid Program: A cross-sectional survey of international site investigators. Journal of Palliative Medicine 23(10): 1292-1293. doi: 10.1089/jpm.2020.0239
Series Publications
Paediatric Gabapentin for pain - series 23
Drake R, Prael G, Phyo Y, Chang S, Hunt J, Herbert A, Mott C, Hynson J, Phillips M, Cossich M, Mherekumombe M, Kim MS, Chong PH, Abitz M, Bernada M, Avery M, Doogue M, Rowett D, Currow DC. Gabapentin for Pain in Pediatric Palliative Care. Journal of Pain and Symptom Management. 2023. doi: https://doi.org/10.1016/j.jpainsymman.2023.11.011. PMID:36357164
Cyclizine for nausea and vomiting - series 12
McNeill R, Prael G, Hunt J, Chang S, Wilcock A, Dunwoodie D, Lau C, Morgan N, Iupati S, Currow DC. Cyclizine pharmacovigilance in hospice/palliative care:net effects for nausea and vomiting. BMJ Supportive and Palliative Care. 2022; 0: 1-7. doi: 10.1136/bmjspcare-2022-003795. PMID:36357164
Non-steroidal anti inflammatory drugs (NSAIDs) - series 16
McNeill R, Boland JW, Wilcock A, Sinnarajah, A, Currow DC. Non-steroidal anti-inflammatory drugs for pain in hospice/palliative care: an international pharmacovigilance study. BMJ Supportive and Palliative Care. 2023 Jan; 0: 1-9. doi: 10.1136/spcare-2022-004154. PMID:36720587
Ascitic taps - series 15
Seah DS, Wilcock A, Chang S, Sousa MS, Sinnarajah A, Teoh CO, Allan S, Chye R, Doogue M, Hunt J, Agar M, Currow DC. Paracentesis for cancer-related ascites in palliative care: An international, prospective cohort study. Palliat Med. 2022 Oct;36(9):1408-1417. doi: 10.1177/02692163221122326. Epub 2022 Sep 15. PMID: 36113139.
Amitriptyline and nortriptyline for neuropathic pain - series 8
Hussein A, Digges M, Chang S, Hunt J, Doogue M, Rowett D, Agar M, Sinnarajah A, Kain D, Allan S, Boland JW, Currow DC. Pharmacovigilance in hospice/palliative care: Net effect of amitriptyline or nortriptyline on neuropathic pain: UTS/IMPACCT Rapid programme international consecutive cohort. Palliat Med. 2022 Jun;36(6):938-944. doi: 10.1177/02692163221085855. [opens external site] Epub 2022 Apr 10. PMID: 35403513.
Blood transfusions - series 5
To T, LeBlanc TW, Eastman P, Neoh K, Agar MR, To LB, Rowett D, Vandersman Z, Currow DC. (2017) The Prospective Evaluation of the Net Effect of Red Blood Cell Transfusions in Routine Provision of Care. J Palliat Med. doi:10.1089/jpm.2017.0072 [opens external site]
To TH, To LB, Currow DC. (2016) Can we detect transfusion benefits in palliative care patients? J Palliat Med. doi:10.1089/jpm.2016.0073 [opens external site]
Dexamethasone for anorexia - series 4
Hatano Y, Moroni M, Wilcock A, Quinn S, Csikos A, Allan SG, Agar M, Clark K, Clayton JM, Currow DC. (2016) Pharmacovigilance in hospice/palliative care: the net immediate and short-term effects of dexamethasone for anorexia. BMJ Supportive & Palliative Care, 6(3):331-7. doi: 10.1136/bmjspcare-2015-001037 [opens external site]
Gabapentin/pregabalin for neuropathic pain - series 3
Sanderson C, Quinn SJ, Agar MR, Chye R, Clark K, Doogue M, Fazekas B, Lee J, Lovell MR, Rowett D, Spruyt O, Currow DC (2016) Pharmacovigilance in hospice/palliative care: net effect of pregabalin for neuropathic pain. BMJ Support Palliat Care. 6(3):323-30. doi: 10.1136/bmjspcare-2014-000825 [opens external site]
Clark K, Quinn SJ, Doogue M, Sanderson C, Lovell M, Currow DC. (2015) Routine prescribing of gabapentin or pregabalin in supportive and palliative care: what are the comparative performances of the medications in a palliative care population? Support Care Cancer. 23(9):2517-20. doi: 10.1007/s00520-015-2837-z [opens external site]
Sanderson C, Quinn S, Agar M, Chye R, Clark K, Doogue M, Fazekas B, Lee J, Lovell M, Rowett D, Spruyt O, Currow D. (2014) Pharmacovigilance in hospice/palliative care: net effect of gabapentin for neuropathic pain. BMJ Supportive & Palliative Care, 5(3):273-80 doi: 10.1136/bmjspcare-2014-000699 [opens external site]
Haloperidol for delirium - series 2
Crawford GB, Agar M, Quinn SJ, Phillips J, Litster C, Michael N, Doogue M, Rowett D, Currow DC. (2013) Pharmacovigilance in Hospice/palliative Care: Net Effect of Haloperidol for Delirium. Journal of Palliative Medicine, 16(11):1-7. doi: 10.1089/jpm.2013.0230 [opens external site]
Agar, M.R., Quin, S.J., Crawford, G.B., Ritchie, C.S., Phillips, J.L., Collier, A., Currow, D.C., (2016). Predictors of mortality for delirium in palliative care. Journal of Palliative Medicine, 19(11) 1205-1209. ahead of print http://doi.org/10.1089/jpm.2015.0416 [opens external site]
Haloperidol for nausea and vomiting - series 6
Digges M, Hussein A, Wilcock A, Crawford GB, Boland JW, Agar MR, Sinnarajah A, Currow DC, Johnson MJ (2017) Pharmacovigilance in Hospice/Palliative Care: Net Effect of Haloperidol for Nausea or Vomiting. J Palliat Med. doi: 10.1089/jpm.2017.0159 [opens external site]
Hypodermoclysis - series 7
Agar MR, Chang S, Amgarth-Duff I, Garcia MV, Hunt J, Phillips JL, Sinnarajah A, Fainsinger R. Investigating the benefits and harms of hypodermoclysis of patients in palliative care: A consecutive cohort study. Palliat Med. 2022 May;36(5):830-840. doi: 10.1177/02692163221082245 [opens external site] PMID: 35531661.
Metoclopramide for nausea - series 1
Currow DC, Vella-Brincat J, Fazekas B, Clark K, Doogue M, Rowett D. (2012) Pharmacovigilance in Hospice/Palliative Care: Rapid Report of Net Clinical Effect of Metoclopramide. Journal of Palliative Medicine, 15(10):1071-5. doi: 10.1089/jpm.2012.0111 [opens external site]
Oxycodone/Naloxone deprescribing - series 9
Clark, K, Byrne, PG, Hunt, J, Brown, L, Rowett, D, Watts, G, Lovell, M and Currow, DC. (2020). Pharmacovigilance in Hospice/Palliative Care: De-Prescribing Combination Controlled Release Oxycodone-Naloxone. J Palliat Med. doi: 10.1089/jpm.2019.0226 [opens external site]